Protara Therapeutics, Inc. Increase (Decrease) in Accrued Liabilities
Protara Therapeutics, Inc. (TARA) reported Increase (Decrease) in Accrued Liabilities of $1.14 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-08-11
- Protara Therapeutics, Inc. increase (decrease) in accrued liabilities for the quarter ending 2026-06-30 was $3.74M.
- Protara Therapeutics, Inc. increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was -$2.60M.
- Protara Therapeutics, Inc. increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was $2.04M, a 1360.00% increase year-over-year.
- Protara Therapeutics, Inc. increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was $922.00K, a 54.80% decline year-over-year.
- Protara Therapeutics, Inc. increase (decrease) in accrued liabilities for fiscal 2025 was $821.00K, a 69.32% decline from fiscal 2024.
- Protara Therapeutics, Inc. increase (decrease) in accrued liabilities for fiscal 2024 was $2.68M.
- Protara Therapeutics, Inc. increase (decrease) in accrued liabilities for fiscal 2023 was -$505.00K, a 167.51% decline from fiscal 2022.
- Protara Therapeutics, Inc. increase (decrease) in accrued liabilities for fiscal 2022 was $748.00K, a 29.86% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $3.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $1.14M 10-Q · filed 2026-08-11 | $3.19M derived: sum of 3 quarters · filed 2026-08-11 | $4.11M derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2026-03-31 | -$2.60M 10-Q · filed 2026-05-13 | -$558.00K derived: sum of 2 quarters · filed 2026-05-13 | $364.00K derived: sum of 3 quarters · filed 2026-05-13 | $89.00K derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2025-12-31 | $2.04M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $2.97M derived: sum of 2 quarters · filed 2026-03-10 | $2.69M derived: sum of 3 quarters · filed 2026-08-11 | $821.00K 10-K · filed 2026-03-10 | |||
| 2025-09-30 | $922.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $647.00K derived: sum of 2 quarters · filed 2026-08-11 | -$1.22M 10-Q · filed 2025-11-10 | -$1.08M derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2025-06-30 | -$275.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$2.15M 10-Q · filed 2026-08-11 | -$2.00M derived: sum of 3 quarters · filed 2026-08-11 | $35.00K derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2025-03-31 | -$1.87M 10-Q · filed 2026-05-13 | -$1.73M derived: sum of 2 quarters · filed 2026-05-13 | $310.00K derived: sum of 3 quarters · filed 2026-05-13 | $9.00K derived: sum of 4 quarters · filed 2026-05-13 | |||
| 2024-12-31 | $140.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $2.18M derived: sum of 2 quarters · filed 2026-03-10 | $1.88M derived: sum of 3 quarters · filed 2026-03-10 | $2.68M 10-K · filed 2026-03-10 | |||
| 2024-09-30 | $2.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $1.74M derived: sum of 2 quarters · filed 2025-11-10 | $2.54M 10-Q · filed 2025-11-10 | $1.96M derived: sum of 4 quarters · filed 2025-11-10 | |||
| 2024-06-30 | -$301.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $496.00K 10-Q · filed 2025-08-11 | -$77.00K derived: sum of 3 quarters · filed 2025-08-11 | $1.10M derived: sum of 4 quarters · filed 2025-08-11 | |||
| 2024-03-31 | $797.00K 10-Q · filed 2025-05-08 | $224.00K derived: sum of 2 quarters · filed 2025-05-08 | $1.40M derived: sum of 3 quarters · filed 2025-05-08 | $2.13M derived: sum of 4 quarters · filed 2025-05-08 | |||
| 2023-12-31 | -$573.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | $601.00K derived: sum of 2 quarters · filed 2025-03-05 | $1.34M derived: sum of 3 quarters · filed 2025-03-05 | -$505.00K 10-K · filed 2025-03-05 | |||
| 2023-09-30 | $1.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $1.91M derived: sum of 2 quarters · filed 2024-11-12 | $68.00K 10-Q · filed 2024-11-12 | $951.00K derived: sum of 4 quarters · filed 2024-11-12 | |||
| 2023-06-30 | $735.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$1.11M 10-Q · filed 2024-08-06 | -$223.00K derived: sum of 3 quarters · filed 2024-08-06 | -$86.00K derived: sum of 4 quarters · filed 2024-08-06 | |||
| 2023-03-31 | -$1.84M 10-Q · filed 2024-05-02 | -$958.00K derived: sum of 2 quarters · filed 2024-05-02 | -$821.00K derived: sum of 3 quarters · filed 2024-05-02 | -$54.00K derived: sum of 4 quarters · filed 2024-05-02 | |||
| 2022-12-31 | $883.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $1.02M derived: sum of 2 quarters · filed 2024-03-13 | $1.79M derived: sum of 3 quarters · filed 2024-03-13 | $748.00K 10-K · filed 2024-03-13 | |||
| 2022-09-30 | $137.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $904.00K derived: sum of 2 quarters · filed 2023-11-03 | -$135.00K 10-Q · filed 2023-11-03 | $436.00K derived: sum of 4 quarters · filed 2023-11-03 | |||
| 2022-06-30 | $767.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$272.00K 10-Q · filed 2023-08-03 | $299.00K derived: sum of 3 quarters · filed 2023-08-03 | $779.00K derived: sum of 4 quarters · filed 2023-08-03 | |||
| 2022-03-31 | -$1.04M 10-Q · filed 2023-05-04 | -$468.00K derived: sum of 2 quarters · filed 2023-05-04 | $12.00K derived: sum of 3 quarters · filed 2023-05-04 | $82.00K derived: sum of 4 quarters · filed 2023-05-04 | |||
| 2021-12-31 | $571.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | $1.05M derived: sum of 2 quarters · filed 2023-03-08 | $1.12M derived: sum of 3 quarters · filed 2023-03-08 | $576.00K 10-K · filed 2023-03-08 | |||
| 2021-09-30 | $480.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $550.00K derived: sum of 2 quarters · filed 2022-11-03 | $5.00K 10-Q · filed 2022-11-03 | $275.00K derived: sum of 4 quarters · filed 2022-11-03 | |||
| 2021-06-30 | $70.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$475.00K 10-Q · filed 2022-08-09 | -$205.00K derived: sum of 3 quarters · filed 2022-08-09 | -$210.00K derived: sum of 4 quarters · filed 2022-08-09 | |||
| 2021-03-31 | -$545.00K 10-Q · filed 2022-05-05 | -$275.00K derived: sum of 2 quarters · filed 2022-05-05 | -$280.00K derived: sum of 3 quarters · filed 2022-05-05 | $300.00K derived: sum of 4 quarters · filed 2022-05-05 | |||
| 2020-12-31 | $270.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-09 | $265.00K derived: sum of 2 quarters · filed 2022-03-09 | $845.00K derived: sum of 3 quarters · filed 2022-03-09 | -$966.00K 10-K · filed 2022-03-09 | |||
| 2020-09-30 | -$5.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $575.00K derived: sum of 2 quarters · filed 2021-11-04 | -$1.24M 10-Q · filed 2021-11-04 | -$1.24M 10-Q · filed 2020-11-12 | -$463.22K derived: sum of 4 quarters · filed 2021-11-04 | ||
| 2020-06-30 | $580.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$1.23M 10-Q · filed 2021-08-05 | -$1.23M 10-Q · filed 2020-07-31 | -$458.22K derived: sum of 3 quarters · filed 2021-08-05 | $646.43K derived: sum of 4 quarters · filed 2021-08-05 | ||
| 2020-03-31 | -$1.81M 10-Q · filed 2021-05-06 | -$1.81M 10-Q · filed 2020-05-13 | -$1.04M derived: sum of 2 quarters · filed 2021-05-06 | $66.43K derived: sum of 3 quarters · filed 2021-05-06 | $21.22K derived: sum of 4 quarters · filed 2021-05-06 | ||
| 2019-12-31 | $772.78K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $1.88M derived: sum of 2 quarters · filed 2021-03-11 | $1.83M derived: sum of 3 quarters · filed 2021-03-11 | $2.05M 10-K · filed 2021-03-11 | |||
| 2019-09-30 | $1.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $1.06M derived: sum of 2 quarters · filed 2020-11-12 | $1.28M 10-Q · filed 2020-11-12 | ||||
| 2019-06-30 | -$45.21K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | $172.57K 10-Q · filed 2020-07-31 | |||||
| 2019-03-31 | $217.78K 10-Q · filed 2020-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |